Constellation Pharmaceuticals Inc (CNST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 12-2016 | |
| Operating Expenses | 9,512 | 0 |
| Operating Income | -9,512 | N/A |
| Interest Expense | 255 | 0 |
| Other Income | 1,775 | 0 |
| Pre-tax Income | -7,992 | 0 |
| Net Income Continuous | -7,992 | N/A |
| Net Income | $-7,992 | $N/A |
| EPS Basic Total Ops | -12.81 | N/A |
| EPS Basic Continuous Ops | -8.31 | N/A |
| EPS Diluted Total Ops | -12.81 | N/A |
| EPS Diluted Continuous Ops | -8.31 | N/A |
| EBITDA(a) | $-9,512 | $N/A |